Serum ferroxidase I and II in uremic patients under conservative treatment and maintenance hemodialysis.
Serum ferroxidase I (ceruloplasmin) and ferroxidase II activities were studied in 49 uremic patients under conservative treatment, in 79 patients undergoing hemodialysis and in 56 healthy subjects, as controls. Ferroxidase I was significantly higher in both groups of patients. Ferroxidase II was significantly elevated only in patients undergoing chronic hemodialysis. The cause of this difference is not clear, but seems to be of considerable interest.
D000328:Adult; D000368:Aged; D002570:Ceruloplasmin / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010088:Oxidoreductases / Q000097:blood*; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood* / Q000201:enzymology / Q000628:therapy
D010088:Oxidoreductases; C023100:ferroxidase II; D002570:Ceruloplasmin